NEW YORK--(BUSINESS WIRE)--April 21, 2006--Callisto Pharmaceuticals, Inc. (AMEX:KAL - News; FWB:CA4), a developer of new drug treatments in the fight against cancer and other major health threats, has announced the online availability of a new audio interview with CEO and CSO Dr. Gary S. Jacob to the online investor information service, WallSt.net, about exciting laboratory findings related to the Company’s proprietary anti-cancer drug candidate, Atiprimod.
